Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer

World Journal of Gastroenterology

Volumn 10, Issue 9, 2004, Pages 1250-1255

  Song, Zhen Ya ^a   Wen, Shu Qun ^a   Peng, Jia Ping ^a   Huang, Xuan ^a   Qian, Ke Da ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; BETA ACTIN; COMPLEMENTARY DNA; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PARAFFIN; PEROXIDASE; PRIMER RNA; REAGENT; STREPTAVIDIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ISOLATION PROCEDURE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA TRANSCRIPTION; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH MUCOSA;

EID: 4444353171     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i9.1250     Document Type: Article

References (37)

1. Ferrara N. Role of Vascular Endothelial Growth Factor in the Regulation of Angiogenesis. Kidney International 1999; 56: 794-814
2. Neufeld G, Cohen T, Gaengrinovitch S, Poltorak AZ. Vascular endothelial growth factor (VEGF) and its receptors. The FASEB Journal 1999; 13: 9-22
3. Tian X, Song S, Wu J, Meng L, Dong Z, Shou C. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC8O3. Biochem Biophys Res Commun 2001; 286: 505-512
4. Kakeji Y, Koga T, Sumiyoshi Y, Shibahara K, Oda 5, Maehara Y, Sugimachi K. Clinical significance of vascular endothelial growth factor expression in gastric cancer. J Exp Clin Cancer Res 2002; 21: 125-129
5. Liu DH, Zhang XY, Fan DM, Huang YX, Zhang JS, Huang WQ, Zhang YQ, Huang QS, Ma WY, Chai YB, Jin M. Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma. World J Gastroenterol 2001; 7: 500-505
6. Ichikura T, Tomimatsu S, Ohkura E, Mochizuki H. Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric cancer. J Surg Oncol 2001; 78: 132-137
7. Rajnakova A, Moochhala S. Goh PM, Ngoi S. Expression of nitric oxide synthase,cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001; 172: 177-185
8. Feng CW, Wang LD, Jiao LH, Liu B, Zheng 5, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous lesion:correlation with clinical features. BMC Cancer 2002; 2: 8-15
9. Tisher E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. The hutnan gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-11954
10. Ferrara N, Gerber H, LeCouter J. The biology of VEGF and its recetors. Nat Med 2003; 9: 669-676
11. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002; 39: 225-237
12. Whang YE, Godley PA. Renal cell carcinoma. Curr Oin Oncol 2003; 15: 213-216
13. Shinkaruk S, Bayle M, Lain G, Deleris G. Vascular endothelial growth factor (VEGF), an emerging target for cancer chemotherapy. Curr Med Chem Anti Canc Agents 2003; 3: 95-117
14. Mesters RM. Angiogenesis in hematologic malignancies. Ann Hematol 2002; 81: S72-74
15. Song ZY, Pang JP, Zhu YL, Qian KD, Zheng S. O-chloroacetylcarbamoyl fumagillol combined with 5-fluorouracil in suppression of the growth of gastric cancer. Chin J Pharmacol Toxicol 2003; 17: 24-28
16. Du JR. Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 2003; 9: 1604-1606
17. Ren J, Dong L, Xu CB, Pan BR. The role of KDR in the interations between human gastric carcinoma cell and vascular endothelial cell. World J Gastroenterol 2002; 8: 596-601
18. Zhang H, Wu J, Meng L, Shou CC. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 2002; 8: 994-998
19. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 2002; 236: 37-42
20. Kimura H, Konishi K, Nukui T, Kaji M, Maeda K, Yabushita K, Tauji M, Miwa A. Prognostic significance of expression of thymidine phosphorylase and vascular endothelial growth factor in human gastric carcinoma. J Surg Oncol 2001; 76: 31-36
21. Maehara Y, Kabashima A, Koga T, Tokunaga E, Takeuchi H, Kakeji Y, Sugimachi K. Vascular invasion and poential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 2000; 128: 408-416
22. Saito H, Tsujitani S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. Expression of vascular endothehial growth factor correlated with hematogenous recurrence in gastric carcinoma. Surgery 1999; 125: 195-201
23. Ohta M, Konno H, Tanaka T, Baba M, Kamiya K, Syouji T, Kondoh K, Watanabe M, Terada M, Nakamura S. The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 2003; 192: 215-225
24. Poon RT, Fan ST, Wong J. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg 2003; 238: 9-28
25. Amioka T, Kitadai Y, Tanaka S, Haruma K, Yoshihara M, Yasui W, Chayama K. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 2002; 38: 1413-1419
26. Maeda K, Kang SM, Onoda N, Ogawa M, Kato Y, Sawada T, Chung KH. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma. Cancer 1999; 86: 566-571
27. Konno H, Baba M, Tanaka T, Kamiya K, Ota M, Oba K, Shoji A, Kaneko T, Nakamura S. Overexpression of vascular endothelial growth factor is responsible for the hematogenous recurrence of early-stage gastric cancinoma. Eur Surg Res 2000; 32: 177-181
28. Kim YB, Han JY, Kim TS, Kim PS, Chu YC. Overexpression of c-H-ras p21 is correlated with vascular endothelial growth factor expression and neovascularization in advanced gastric carcinoma. J Gastroenterol Hepatol 2000; 15: 1393-1399
29. Saito H, Tujitani S, Ikeguchi M, Ikeguchi M, Maeta M, Kaibara N. Neoagogenesis and relationship to nuclear p53 accumulation and vascular endothehial growth factor expression in advanced gastric carcinoma. Oncology 1999; 57: 164-172
30. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C. Hypoxiainducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003; 93: 664-673
31. Joo TE, Sohn YH, Joo SY, Lee WS, Min SW, Park CH, Rew JS, Choi SK, Park CS, Kim YJ, Kim SJ. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer. Korean J Intern Med 2002; 17: 211-219
32. Joo YE, Rew JS, Seo YH, Choi SK, Kim YJ, Park CS, Kim SJ. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer. J Chin Gastroenterol 2003; 37: 28-33
33. Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591-595
34. DulaK J, Jozkowicz A, Dembinska KA, Guevara I, Zdzienicka A, Zmudzinska GD, Florek I, Wojtowicz A, Szuba A, Cooke JP. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20: 659-666
35. Konopka TE, Barker JE, Bamford TL, Guida E, Anderson RL, Stewart AG. Nitric oxide synthase II gene disruption - Implications for tumor growth and vascular endothelial growth factor production. Cancer Res 2001; 61: 3182-3187
36. Kisley LR, Barrett BS, Bauer AK, Dwyer Nield LD, Barthel B, Meyer AM, Thompson DC, Malkinson AM. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res 2002; 62: 6850-6856
37. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-induaible factor-1 activity by nitric oxide. Blood 2000; 95: 189-197